ResMed (RMD) Reports In-Line Q3 EPS, Miss on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.46 -1.01%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.71, in-line with the analyst estimate of $0.71. Revenue for the quarter came in at $514.2 million versus the consensus estimate of $519.87 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
